There is no effect of the treatment on tumor-associated macrophages in this model; this might be explained by the fact that there was much less tumor-associated macrophage recruitment in MSTO211H compared to ACC-Meso-1 tumors, which corresponded to a low baseline expression of CCL2 in MSTO211H in vivo and in vitro. This evidence concerns the gene CCL2 and neoplasm.